Vitamin B1 derivative trial aims to put brakes on Alzheimer's decline
Disease control
Recruiting now
This study is testing whether a form of vitamin B1 called benfotiamine can slow down the worsening of memory and daily function in people with early Alzheimer's disease. Over 400 participants will take either the study drug or a placebo for 18 months to see if it is safe and effe…
Phase: PHASE2 • Sponsor: Alzheimer's Disease Cooperative Study (ADCS) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC